ClinicalTrials.Veeva

Menu

Evaluation of Morphology Abnormal Cornea Stability With Corneal Biomechanical

T

Tianjin Eye Hospital

Status

Completed

Conditions

Keratoconus, Stable

Treatments

Other: Pentacam and Corvis ST

Study type

Observational

Funder types

Other

Identifiers

NCT05748002
2023002

Details and patient eligibility

About

To evaluate the corneal biomechanical properties of stable eyes with abnormal morphology, and introduce a biomechanical stable index to evaluate the stability of the eyes with abnormal morphology at the first diagnosis.

Enrollment

315 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Best corrected visual acuity (BCVA) ≥ 20/20;
  2. No other eye diseases except myopia and astigmatism;
  3. The cornea was transparent, and there was no cloud or pannus;
  4. No clinical manifestation of keratoconus(Corneal stromal thinning, Cone-shaped anterior protrusions, Fleischers ring, Vogts striae, Epithelial or subepithelial scarring) Exclusion Criteria:1) corneal disease;
  1. ocular trauma; 3) Patients were required to stop wearing soft contact lenses for at least 2 weeks and rigid contact lenses for at least 4 weeks before examination; 4) Pregnant and lactating women;

Trial design

315 participants in 4 patient groups

stable group
Treatment:
Other: Pentacam and Corvis ST
subclinical keratoconus
Treatment:
Other: Pentacam and Corvis ST
normal group
Treatment:
Other: Pentacam and Corvis ST
follow up group
Treatment:
Other: Pentacam and Corvis ST

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems